Rein Therapeutics
RNTX
#10245
Rank
NZ$0.10 B
Marketcap
NZ$1.18
Share price
4.11%
Change (1 day)
-61.50%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2026 (TTM): -NZ$36.11 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$39.04 Million, an increase over its 2024 earnings that were of -NZ$50.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$36.11 Million-7.5%
2025 -NZ$39.04 Million-21.99%
2024 -NZ$50.04 Million83.16%
2023 -NZ$27.32 Million-44.49%
2022 -NZ$49.21 Million3.92%
2021 -NZ$47.35 Million29.81%
2020 -NZ$36.48 Million-31.58%
2019 -NZ$53.32 Million-6.1%
2018 -NZ$56.78 Million38.66%
2017 -NZ$40.95 Million26.63%
2016 -NZ$32.34 Million